Phase 1 Study of BIIB022 (Anti-IGF-1R Monoclonal Antibody) in Relapsed/Refractory Solid Tumors

This study has been completed.

Study NCT00555724 Information provided by Biogen Idec

First Received: October 31, 2007 Last Updated: January 6, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	July 2010
Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)